$P

Colgrove John sold $7.7M of P (indirect holdings)

Colgrove John (Chief Visionary Officer) sold 89,720 indirectly-held shares of Everpure, Inc. (P) at an average of $85.66 ($85.63–$86.05, $7.69M total) across 2 trades on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Colgrove John
Published Aug 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$P
Neutral
medium confidence
Mentioned
$P
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity or interpret the sale as a sentiment signal, but there is no accompanying guidance, earnings, or operational catalyst in the text.

02

Market read

A $7.69M insider sale in Everpure is newly disclosed via Form 4, but it is pre-arranged and lacks fundamental updates.

03

What to watch

The filing does not disclose reasons for the sale, and the net effect (0 shares after sale) can be driven by diversification or tax planning rather than valuation concerns.

Relevance 5/10Novelty 5/10Timing: filed 2026-08-06, transaction dated 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for Everpure, Inc. (P) by Colgrove John, an officer/director, reporting an open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$PNeutralMedium confidence
Context

Everpure, Inc. Form 4 shows officer Colgrove John sold $7.69M of P via an open-market sale under a 10b5-1 plan, leaving 0 shares.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

The filing is a primary-source Form 4 and the transaction size is material, but it is explicitly under a pre-arranged 10b5-1 plan and does not include new operating or guidance information.

Market effects

No clear sector read-through because the disclosure is company-specific and does not cite business developments.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Everpure, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Colgrove John

    Officer and director who sold shares indirectly under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure Stock Surges As S&P 500 Inclusion Fuels Breakout

Everpure Inc. (NYSE: P) stock rose 4.48% after positive product coverage and S&P 500 inclusion. The company reaffirmed its 2027 outlook and provided 2028 targets above expectations. Everpure reported $3.66B revenue, 70.2% gross margin, and a P/E ratio of 496. Its inclusion in the S&P 500 is expected to drive structural demand.

$PHigh

Everpure Stock Surges As 2027–2028 Guidance Fuels Breakout

Everpure Inc. (NYSE: P) shares rose 4.48% on October 7, 2026, after reaffirming its 2027 guidance and providing 2028 targets exceeding Wall Street expectations. The company expects $940–$960M in adjusted operating income and $5.03–$5.07B in revenue for 2027. Everpure is also being added to the S&P 500, which may drive further demand. The stock trades at a P/E of 496 and has seen significant momentum, reaching $152.66 from the mid-$90s in recent weeks.

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.